Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wise Diagnostic Systems is a private U.S. clinical diagnostics company focused on molecular infectious disease testing and related laboratory services. The company operates a CLIA-certified clinical medical laboratory in the Houston-area market and offers PCR-based diagnostic panels for infections including urinary tract, wound, respiratory, gastrointestinal, and COVID-19 testing, along with pharmacogenomic services. Its core value proposition is rapid, actionable reporting for physicians, nursing homes, long-term care facilities, and specialists, supported by patient-friendly specimen collection workflows. Wise Diagnostic Systems appears to be a service-oriented commercial diagnostics business rather than a therapeutics developer, with emphasis on sensitivity, specificity, and 24-hour turnaround for many tests.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wise Diagnostic Systems.